FEMSelect Competitors and Similar CompaniesClear all
FEMSelect's competitors and similar companies include Cavaterm, Viveve, Geratherm and Femasys.
 FEMSelect FEMSelect is a healthcare company focusing on the treatment of pelvic organ prolapse (POP) condition. |  Cavaterm Cavaterm is an endometrial ablation technique for the treatment of heavy periods developed by Veldana Medical. |  Geratherm Geratherm Medical is a medtech company that develops and produces medical device solutions. |  Femasys Femasys is a biomedical company that provides women’s healthcare solutions including minimally invasive and non-surgical product technologies. | ||
Founding Date | Founding Date 2012 | Founding Date 1990 | Founding Date 2005 | Founding Date 1900 | Founding Date 2004 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations HQ | Locations Morges, CH HQ | Locations Englewood, US HQ | Locations Geschwenda, DE HQ | Locations Suwanee, US HQ |
Employees | Employees 157% increase | Employees N/A | Employees 6735% decrease | Employees 15518% decrease | Employees 288% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 4.3 k | Valuation ($) 19.8 m | Valuation ($) 30.7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $6.4m (FY, 2021) | Revenue (est.) €14m (FY, 2024) | Revenue (est.) $2.3m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $5.8m (FY, 2021) | Cost of goods €8m (FY, 2024) | Cost of goods $872.4k (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $620k (FY, 2021) | Gross profit €12.1m (FY, 2024) | Gross profit $1.4m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($22m) (FY, 2021) | Net income €653k (FY, 2024) | Net income ($18.6m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 25.2m | Total funding raised N/A | Total funding raised $ 63.9m |
For sources of this data, please see the company profile
View Company Profiles
Cavaterm
HQ
Morges, CH
Cavaterm is an endometrial ablation technique for the treatment of heavy periods developed by Veldana Medical.
View company
Viveve
HQ
Englewood, US
Employees
67↓ 35% decrease
Viveve is a women's health and wellness company.
View companyGeratherm
HQ
Geschwenda, DE
Employees
155↓ 18% decrease
Geratherm Medical is a medtech company that develops and produces medical device solutions.
View companyFemasys
HQ
Suwanee, US
Employees
28↑ 8% increase
Femasys is a biomedical company that provides women’s healthcare solutions including minimally invasive and non-surgical product technologies.
View company